Things got heated this week as GPs fired a few more volleys in their turf war against pharmacists
We saw the committee undertaking Queensland’s Parliamentary Inquiry into the pharmacy sector release its findings, which were welcomed by stakeholders including the Pharmacy Guild and the PSA. GPs were perhaps unsurprisingly unimpressed by the recommendation that pharmacists work to full scope of practice, with the AMA national president, Dr Tony Bartone, saying they are a “second best” alternative, and Queensland branch president Dr Dilip Dhupelia claiming that pharmacists simply weren’t qualified to dispense emergency and repeat scripts.
Meanwhile Ramsay welcomed the findings, particularly the lack of a recommendation for increased ownership regulation.
And during the recent GP18 conference, frequent pharmacy critic Dr Evan Ackermann asked Greens leader Senator Richard Di Natale whether he thought the Guild exerted “undue influence”—prompting the Senator to call for greater transparency in CPA negotiations and describing the existing model as “backroom deals“. Guild NSW branch committee member Adele Tahan responded by getting in touch with her local Greens MP to call for discussion and clarification.
And Anthony Tassone criticised other recent pot shots from the AMA, saying that such attitudes drive health practitioners back into silos.
We learned how GP pharmacists performed in an asthma management pilot. Stakeholders warned that only including pain management programs in the new Gold tier of private health insurance could cause trouble.
The Guild welcomed an intervention by Kelly O’Dwyer in a court case which it says will provide employers with certainty around casual workers’ entitlements, and fast-tracked tax cuts for small and medium businesses passed Parliament.